Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02MPT
|
|||
| Former ID |
DNCL003617
|
|||
| Drug Name |
MAGE-A3 immunotherapeutic
|
|||
| Indication | Melanoma [ICD-11: 2C30] | Phase 3 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [1] | ||
| Type-2 diabetes [ICD-11: 5A11] | Phase 3 | [1] | ||
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of GlaxoSmithKline. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.